260 related articles for article (PubMed ID: 28628081)
1. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency.
Wang T; Yu Q; Li J; Hu B; Zhao Q; Ma C; Huang W; Zhuo L; Fang H; Liao L; Eugene Chin Y; Jiang Y
Nat Cell Biol; 2017 Jul; 19(7):833-843. PubMed ID: 28628081
[TBL] [Abstract][Full Text] [Related]
2. PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells.
Chen T; Wang T; Liang W; Zhao Q; Yu Q; Ma CM; Zhuo L; Guo D; Zheng K; Zhou C; Wei S; Huang W; Jiang J; Liu J; Li S; He J; Jiang Y; Zhong N
Cancer Res; 2019 Apr; 79(7):1383-1397. PubMed ID: 30683654
[TBL] [Abstract][Full Text] [Related]
3. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
[TBL] [Abstract][Full Text] [Related]
4. Metformin activates KDM2A to reduce rRNA transcription and cell proliferation by dual regulation of AMPK activity and intracellular succinate level.
Tanaka Y; Konishi A; Obinata H; Tsuneoka M
Sci Rep; 2019 Dec; 9(1):18694. PubMed ID: 31822720
[TBL] [Abstract][Full Text] [Related]
5. The decisive role of fumarase: Responsive signaling to glucose deficiency.
Yu Q; Wang T; Jiang Y
Mol Cell Oncol; 2018; 5(4):e1363848. PubMed ID: 30250906
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
[TBL] [Abstract][Full Text] [Related]
7. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
9. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
10. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
12. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
[TBL] [Abstract][Full Text] [Related]
13. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
[TBL] [Abstract][Full Text] [Related]
14. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
15. Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.
Ishimura E; Nakagawa T; Moriwaki K; Hirano S; Matsumori Y; Asahi M
Cancer Sci; 2017 Dec; 108(12):2373-2382. PubMed ID: 28973823
[TBL] [Abstract][Full Text] [Related]
16. Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
Fu LN; Wang YQ; Tan J; Xu J; Gao QY; Chen YX; Fang JY
Oncogene; 2018 Jan; 37(3):389-402. PubMed ID: 28945223
[TBL] [Abstract][Full Text] [Related]
17. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
18. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
19. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
20. Glucose-induced expression of MIP-1 genes requires O-GlcNAc transferase in monocytes.
Chikanishi T; Fujiki R; Hashiba W; Sekine H; Yokoyama A; Kato S
Biochem Biophys Res Commun; 2010 Apr; 394(4):865-70. PubMed ID: 20206135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
